Want to learn more? Check out our

Role of Neuroendovascular Treatment in Intracranial Hypertension and Pseudotumor Cerebri

Dr. Starke discusses his experience with neuroendovascular treatment and its important role in patients with IIH

On October 25th we welcomed Dr. Robert Starke from the University of Miami Miller School of Medicine to present the Role of Neuroendovascular Treatment in Intracranial Hypertension and Pseudotumor Cerebri. Dr. Starke is a neurosurgeon and neurointerventionalist and holds an impressive and extensive list of publications and accolades with many related to the treatment of intracranial hypertension.

Dr. Pierre Gobin was the moderator for this talk. He is an interventional radiologist who specializes in endovascular treatment of cerebral aneurysms at Weill Cornell Medicine in New York.

In case you missed it, the full webinar is available to watch here.

Here are some key points of his lecture:

  • It is imperative that a patient with IIH, who is being referred for surgical options IIH, undergo a complete and through work up.
  • It is important to thoroughly review and re-review all imaging studies to decide if more invasive studies are warranted such as cerebral angiography. This procedure can provide more detailed information and can detect lesions that may not be seen on a CT scan or MRI.
  • If a patient with IIH has maximized their medical therapy without relief of symptoms, they should be considered for neurosurgical intervention. Some surgical options include a ventriculoperitoneal (VP) or Lumboperitoneal (LP) stunt, optic nerve sheath fenestration (ONSF), and venous sinus stenting (VSS). Determination of the above is individualized to the patient.
  • Dr. Starke presented his team’s research, “A Prospective Pilot Study of Intraparenchymal & Intravenous Cerebral Pressure Assessment During Venous Sinus Stenting for IIH: Detailed Evaluation of Ophthalmological, Neurological & Radiographic Outcomes”. It is now in press with the Journal of Neurosurgery.
  • After review of the 10 patients in his prospective study, he noted that not all patients had a BMI over 30, or obese.
  • Dr. Starke reviewed his findings that patients with IIH who had venous sinus stenting (VSS) had improvement of their visual and headache symptoms, far superior compared to VP, LP, and ONSF.

Thank you Dr. Starke for sharing your expertise and research on Idiopathic Intracranial Hypertension IIH.

If you would like to get in touch with Dr. Starke you can find him on these social media outlets: Facebook, Instagram and Twitter, or to make an appointment to see him as a patient.

Our next webinar will be held on November 21st at 4 pm EST with Dr. Dorothea Altschul. If you would like to attend this free lecture, click here.

Related articles

Omar Choudhri, MD
March 7, 2024
Dr Omar Choudhri discusses the factors that contribute to the pathophysiology of IIH and advanced imaging to help aid in the diagnosis...
December 14, 2023
Dr Plenty discusses the importance in understanding how these two conditions are interrelated as over 95 of people affected with IIH are...

Stay Informed

Stay up-to-date on the latest research and resources on this Hub by subscribing to our monthly newsletter

Like what you are seeing?

Join our next webinar.

Thank you! You’re registration is complete for:

IIH Practitioner Series

Join our June webinar to discuss GLP1’s and its impact on patients with obesity.

June 24 at 9:30 am ET